ARCHIVES

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

Garfinkel to Retire From ACS; Health to Succeed Him

July 20, 1990

NCI Forms Lung Cancer Program for Research On Early Detection, Treatment.

June 23, 2006

In Brief: Cancer Center Scientist Set For Space Launch; NIH French Anderson Negotiating With USC

June 5, 1992

Richard Pestell, of Georgetown University, to direct Kimmel Cancer Center at Thomas Jefferson University.

November 11, 2005

Austria Has highest Cancer Rate, Little NCI Support

June 17, 1977

Shared Decisionmaking Called For In PSA Screening For Ages 55-69

May 31, 2013